Feature Articles
Use of the Levonorgestrel Intrauterine Device in Women With Type 2 Diabetes
Benjamin Lang, Tatiana Josephy, Elizabeth Micks, Erin McCoy and Sarah Prager
Clinical Diabetes 2018 Apr; cd170028. https://doi.org/10.2337/cd17-0028

Article Information

DOI 
https://doi.org/10.2337/cd17-0028
Published By 
American Diabetes Association
Print ISSN 
0891-8929
Online ISSN 
1945-4953
History 
  • Published May 2, 2018.

Article Versions

Copyright & Usage 
© 2018 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0 for details.

Author Information

  1. Benjamin Lang1,
  2. Tatiana Josephy2,
  3. Elizabeth Micks3,
  4. Erin McCoy3 and
  5. Sarah Prager3
  1. 1University of Washington School of Medicine, Seattle, WA
  2. 2University of Chicago Pritzker School of Medicine, Chicago, IL
  3. 3Department of Obstetrics and Gynecology, University of Washington, Seattle, WA
  1. Corresponding author: Benjamin Lang, blang{at}uw.edu

Statistics from Altmetric.com

Article usage

Article usage: April 2018 to November 2018

Rendering graph...
AbstractFullPdf
Apr 2018100
May 2018214017
Jun 201811608
Jul 2018514819
Aug 20186601036
Sep 2018512830
Oct 2018271720
Nov 20183611

Back to top
Clinical Diabetes: 36 (4)

Current Issue

October 2018
Volume 36, Issue 4

Sign up to receive current issue alerts
View Selected Citations (0)
Article Alerts
Email Article
Citation Tools
Add to Selected Citations

Use of the Levonorgestrel Intrauterine Device in Women With Type 2 Diabetes
Benjamin Lang, Tatiana Josephy, Elizabeth Micks, Erin McCoy, Sarah Prager
Clinical Diabetes Apr 2018, cd170028; DOI: 10.2337/cd17-0028
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section